Decreased expression of tumour suppressor Bax‐interacting factor‐1 (Bif‐1), a Bax activator, in gastric carcinomas

By Lee Jong Woo   Jeong Eun Goo   Soung Young Hwa   Nam Suk Woo   Lee Jung Young   Yoo Nam Jin   Lee Sug Hyung  

Pathology, Vol. 38, Iss. 4, 2006-08 ,pp. : 312-315

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expression of Cyclooxygenase-1 and-2 in Urinary Bladder Carcinomas In Vivo and In Vitro and Prostaglandin E₂ Synthesis in Cultured Bladder Cancer Cells

By Boström Peter   Aaltonen Vesa   Söderström Karl-Ove   Uotila Pekka   Maato Matti  

Pathology, Vol. 33, Iss. 4, 2001-11 ,pp. : 469-474

Ashgate Publishing Ltd

Access to resources Recommend Favorite

TGF-βRII, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder

By Saetta Angelica A.   Korkolopoulou Penelope   Karlou Maria   Levidou Georgia   Goudopoulou Athina   Thymara Irene   Stamatelli Angeliki   Tzivras Michalis   Michalopoulos Nikolaos V.   Thomas-Tsagli Euphemia   Patsouris Efstratios  

Pathology, Vol. 39, Iss. 4, 2007-08 ,pp. : 425-432

Ashgate Publishing Ltd

Access to resources Recommend Favorite

nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of vater

By Lee C.   Pirdas-Zivcic Anne  

Pathology, Vol. 26, Iss. 4, 1994-10 ,pp. : 448-452

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cumulative expression of HIF--1--alpha, Bax, Bcl--xL and P53 in human colorectal cancer

By Wincewicz Andrzei   Sulkowska Mariola   Koda Mariusz   Sulkowski Stanislaw  

Pathology, Vol. 39, Iss. 3, 2007-07 ,pp. : 334-338

Ashgate Publishing Ltd

Access to resources Recommend Favorite